Stephanie A. Lodise Ph.D.

Partner

Philadelphia
T +1.215.564.8918
F +1.215.568.3439

Overview

Stephanie Lodise's practice focuses on all phases of highly sophisticated patent prosecution for clients in the pharmaceutical, biotechnology and chemical arts, with considerable experience in all areas of patent prosecution and analysis. Stephanie's experience working in the patent department of a major pharmaceutical company provided her with tremendous insight into the issues faced by in-house counsel. She has since served as in-house counsel for current clients, working onsite to provide one-on-one patent services. Large portfolios require adroit management, and Stephanie demonstrates her proficiency by directing the patent prosecution of complex portfolios both in the U.S. and abroad. Stephanie was instrumental in obtaining key patent coverage on new technologies for pharmaceutical, medical device and material science clients that have since been commercialized or licensed. As one of the few patent lawyers in the country with a Ph.D. in synthetic organic chemistry and experience as a research chemist at a major pharmaceutical company, Stephanie's skills in small molecule design, synthesis, formulation and use are highly valued among her many life sciences clients.

Select Experience

  • Prosecutes, manages and advises on U.S. and international patent portfolios encompassing commercially marketed oncological, antiviral and radio-labeled pharmaceuticals.
  • Prosecutes, manages and advises on U.S. and international patent portfolios encompassing isotopically-labeled small molecules.
  • Prosecutes, manages and advises on U.S. and international patent portfolios encompassing drug repositioning technologies.
More »

Experience

  • Prosecutes, manages and advises on U.S. and international patent portfolios encompassing commercially marketed oncological, antiviral and radio-labeled pharmaceuticals.
  • Prosecutes, manages and advises on U.S. and international patent portfolios encompassing isotopically-labeled small molecules.
  • Prosecutes, manages and advises on U.S. and international patent portfolios encompassing drug repositioning technologies.
  • Prosecutes reissue and ex parte reexamination applications for small molecule pharmaceutical compounds and medical devices.
  • Prepares and argues appeals to the Patent Trial and Appeal Board. 
  • Creates patent portfolios for pharmaceutical startup companies, creating assets critical in obtaining capital investments.
  • Provides advice and performs freedom-to-operate assessments in support of due diligence analyses for small molecule pharmaceuticals.
  • Provides advice and performs freedom-to-operate assessments in support of due diligence analyses for dermatological and transdermal compositions.
  • Advises on and prepares applications for Patent Term Extensions.
  • Provides advice on the impact of the judicially-created doctrine of obviousness-type double patenting on pharmaceutical patent portfolios.

Recognitions and Memberships

Recognitions

  • Pennsylvania Super Lawyers "Rising Star" (2011 to 2012; 2014 to 2015)
  • Co-Recipient of the 2011 Thomas Alva Edison Patent Award in the Pharmaceuticals category

Memberships

  • Intellectual Property Owners, Inc.: Pharmaceutical & Biotechnology Issues Committee

Industries

Prior Positions

  • Philadelphia Intellectual Property Association: Board of Governors (2008 to 2010)

Admissions

  • U.S. District Court, Eastern District of Pennsylvania
  • U.S. District Court, District of New Jersey
  • U.S. Patent and Trademark Office, Registration No. 51,430
  • New Jersey
  • Pennsylvania

Education

  • J.D., Rutgers University School of Law, Camden, 2005, with highest honors, graduated first in class; Notes and Casenotes Editor, Rutgers Law Journal
  • Ph.D., Organic Chemistry, University of Pennsylvania, 2000; recipient of American Chemical Society Division of Organic Chemistry Graduate Fellowship (1998 to 1999)
  • B.A., Chemistry, Rutgers University, 1995, with honors, Phi Beta Kappa